Latest Articles
Acrivon Therapeutics’ SWOT analysis: stock shows promise in cancer pipeline - Investing.com
Acrivon Therapeutics’ SWOT analysis: stock shows promise in cancer pipeline Investing.com
Published: May 21, 2026, 2:57 p.m.
Amanda Peet says she's cancer-free after breast cancer diagnosis, returns to acting in Fantasy Life - artthreat.net
Amanda Peet says she's cancer-free after breast cancer diagnosis, returns to acting in Fantasy Life artthreat.net
Published: May 21, 2026, 6:45 a.m.
New treatment offers hope for endometrial cancer patients - New York Post
New treatment offers hope for endometrial cancer patients New York Post
Published: May 20, 2026, 6:34 p.m.
How Investors Are Reacting To Merck (MRK) TroFuse ADC’s Breakthrough Endometrial Cancer Phase 3 Trial Results - Yahoo Finance
How Investors Are Reacting To Merck (MRK) TroFuse ADC’s Breakthrough Endometrial Cancer Phase 3 Trial Results Yahoo Finance
Published: May 20, 2026, 6:22 p.m.
Recognizing and Managing Immune-Related Adverse Events in Endometrial Cancer - OncLive
Recognizing and Managing Immune-Related Adverse Events in Endometrial Cancer OncLive
Published: May 20, 2026, 2:57 p.m.
New therapy bests chemo to improve survival in endometrial cancer - Rare Cancer News
New therapy bests chemo to improve survival in endometrial cancer Rare Cancer News
Published: May 20, 2026, 1:14 p.m.
New drug approach offers hope for patients with recurrent aggressive cancers - Fox News
New drug approach offers hope for patients with recurrent aggressive cancers Fox News
Published: May 20, 2026, 11 a.m.
GIST, SNUH identify beneficial bacterium linked to lower endometrial cancer recurrence - koreabiomed.com
GIST, SNUH identify beneficial bacterium linked to lower endometrial cancer recurrence koreabiomed.com
Published: May 20, 2026, 7:57 a.m.
Merck's Sac-TMT meets both endpoints in phase 3 endometrial cancer trial - MSN
Merck's Sac-TMT meets both endpoints in phase 3 endometrial cancer trial MSN
Published: May 20, 2026, 6:16 a.m.
How Sacituzumab Trial Success In Endometrial Cancer At Merck (MRK) Has Changed Its Investment Story - simplywall.st
How Sacituzumab Trial Success In Endometrial Cancer At Merck (MRK) Has Changed Its Investment Story simplywall.st
Published: May 20, 2026, 5:46 a.m.
Link copied to clipboard!